Welcome to another edition of the Blossom TMS Provider Spotlight series, where we showcase key figures making waves in the TMS industry. Today, we’re excited to sit down with Christian Hirschbeck, our very own CEO at SEBERS Medical. Christian has over 15 years of experience in the field of TMS and neurostimulation, leading the way with innovative solutions like the Blossom TMS device. Let’s get to know him better and dive into his journey with TMS, his vision for the future, and the work he’s doing at SEBERS Medical. Blossom TMS: Christian, thank you for joining us! Can you tell us how you first got involved with TMS? Christian Hirschbeck:It’s great to be here! My journey with TMS started over 15 years ago when I was working for a neurophysiology company. We had a joint venture with a TMS startup, and that’s where I had my first contact with the technology. I was managing parts of product development for EEG solutions at the time, and we began exploring the combination of EEG and EMG with TMS. We were part of the manufacturing of the first German-made TMS stimulator on the market, and from there, we helped establish TMS in Germany. Blossom TMS: What drew you to TMS as a field?Christian Hirschbeck:What attracted me to TMS was its potential to not only diagnose but also treat patients. In neurophysiology, most of the focus is on diagnosis, but TMS opened up the possibility of actually helping patients improve their quality of life. That was a major factor for me. Being able to not only identify problems but provide a solution really stood out. Blossom TMS: What is your technical background, and how did that play a role in developing TMS technology? Christian Hirschbeck:I’m an electrical engineer by training, originally from Austria. My early career was in telecommunications, but I transitioned to neurostimulation and eventually became focused on sales and marketing. My technical background helps me understand the mechanics behind TMS devices, which has been invaluable as we’ve developed the Blossom TMS machine. While today’s devices are much more advanced than the older models, that engineering knowledge is still a huge advantage. Blossom TMS: How did the Blossom TMS device come about?Christian Hirschbeck:The Blossom TMS device was born out of a desire to make TMS more accessible and easier to use in clinical settings. Many devices on the market are research-focused, with too many complicated controls. We wanted to create a streamlined, easy-to-use device that could be widely adopted by clinicians. That’s where our slogan, “We Make TMS Easy,” comes from. I firmly believe that simplicity is the key to making TMS a go-to treatment. Blossom TMS: What makes the Blossom TMS device stand out from others on the market? Christian Hirschbeck:One of the biggest differentiators is our coil cooling system. We partnered with a Korean company, REMED, to ensure that we had the most reliable coil cooling on the market. Oil cooling, in particular, is key for performance and longevity, allowing our machines to run all day without overheating. Most devices use air cooling, which doesn’t perform as well, especially in warmer climates. Our oil-based cooling system ensures that the Blossom TMS is reliable, low maintenance, and incredibly efficient. Blossom TMS: What’s your vision for the future of TMS? Christian Hirschbeck:I see TMS evolving beyond just mental health treatments. While depression treatment is currently the most common use, I believe that TMS has huge potential in neurology, particularly in areas like stroke rehabilitation and pain management. In the future, I think TMS could become a standard tool in hospitals worldwide, just like EEG and EMG devices. At SEBERS Medical, we’re already working on expanding TMS applications to include neurology. Blossom TMS: You’ve worked hard to make the Blossom TMS device affordable. Why is that important to you? Christian Hirschbeck:Affordability is crucial if we want to see TMS become more widely used. At SEBERS Medical, we’re a privately owned company, so we don’t have investors pressuring us to inflate prices. We can focus on creating high-quality devices at reasonable prices. I don’t think that machines costing over $100,000 are the future of TMS. Devices like the Blossom TMS, which are priced around $50,000, will help make TMS more accessible to clinicians and, in turn, more available to patients.Blossom TMS: What challenges do new TMS providers face, and how does SEBERS Medical help? Christian Hirschbeck:New providers face two main challenges: technical concerns and business operations. On the technical side, we ensure that our machines are low-maintenance with no hidden fees like pay-per-use charges. On the business side, we offer extensive support, from training on how to use the machines to guidance on coding, insurance reimbursement, and even marketing. Our goal is to make the transition into offering TMS as seamless as possible for clinics. Blossom TMS: Finally, what’s next for SEBERS Medical and the Blossom TMS device? Christian Hirschbeck:We’re constantly looking for ways to innovate and improve. We’re working on expanding the clinical applications of TMS while maintaining the affordability and ease of use that we’ve become known for. We believe that the future of TMS is bright, and we’re excited to be part of that journey. At SEBERS Medical, we’re committed to making TMS more accessible to people around the world. That wraps up our conversation with Christian Hirschbeck, CEO of SEBERS Medical. His passion for advancing TMS technology is clear, and his vision for making TMS accessible, affordable, and effective is driving the next phase of growth for SEBERS Medical and the Blossom TMS device. Stay tuned for more updates as we continue to lead the way in TMS innovation!
TMS Coverage for Adolescents: What You Need to Know About Aetna’s Policy
Transcranial Magnetic Stimulation (TMS) is now available for adolescents as young as 15, and insurance providers like Aetna are expanding their coverage to meet this growing demand. As of now, Aetna has updated their policies to cover TMS for adolescents aged 15 and older with Major Depressive Disorder (MDD), but this shift is likely to inspire other insurance companies to follow suit. Key Points from Aetna’s TMS Coverage Policy: Are Other Insurance Providers Following? While Aetna is a leader in expanding adolescent TMS coverage, many other insurance providers are likely to follow this trend. Given the effectiveness and growing recognition of TMS as a non-invasive treatment for MDD, it’s expected that other insurers like Humana and BlueCross BlueShield may soon update their policies to include adolescent coverage as well. What Should Providers Do? For clinics and providers, the best practice is to check directly with insurance companies regarding their specific coverage for adolescent TMS. Since each insurance provider has its own set of guidelines, verifying coverage before initiating treatment is key to ensuring the best possible care for patients. Conclusion The expansion of TMS coverage for adolescents marks a significant step forward in treating mental health conditions in younger populations. As more insurance companies update their policies, TMS will become even more accessible, allowing more adolescents to benefit from this life-changing therapy. If you want to learn more about how Blossom TMS can help adolescents, visit our blog or contact us today. Source: https://www.aetna.com/cpb/medical/data/400_499/0469.html
Suicide Prevention Month: How TMS is Helping to Save Lives
September is Suicide Prevention Month in the U.S., a time to raise awareness about a crisis that affects millions of individuals and families. Suicide is the 10th leading cause of death in the country, with mental health challenges like depression playing a significant role in many cases. As a community, we must come together to spread the word about life-saving interventions like Transcranial Magnetic Stimulation (TMS), a non-invasive, effective treatment for depression. How TMS Can Help Address This Crisis TMS has emerged as a powerful tool in the fight against treatment-resistant depression, offering hope to individuals who haven’t found relief through traditional therapies like medication or talk therapy. By targeting specific areas of the brain linked to mood regulation, TMS can effectively reduce the symptoms of depression, including those that often lead to suicidal thoughts. In fact, clinical studies have demonstrated the positive impact of TMS in reducing depression and suicidal ideation. This non-invasive therapy is particularly beneficial for those who have not responded to antidepressants, providing a pathway to recovery that’s free from medication side effects. Why We Must Spread the Word TMS is part of the growing field of Interventional Psychiatry, which includes a range of innovative, non-drug treatments for mental health conditions. However, too few people are aware of these options. We need to amplify the conversation about the benefits of TMS, ensuring that both healthcare providers and patients know that help is available. By spreading the word, we can help our communities understand that there are effective treatments beyond medication. TMS, with its proven track record in treating depression, offers a ray of hope for those battling suicidal thoughts and feelings. Join the Effort At SEBERS Medical, we are committed to raising awareness about the benefits of TMS and other interventional psychiatry practices. Our Blossom TMS device is designed to make this life-saving treatment more accessible, with features that reduce overhead and improve clinic efficiency. As we recognize Suicide Prevention Month, let’s work together to ensure that those struggling with depression and suicidal ideation know that TMS can help. Together, we can make a difference in the fight against suicide. Learn More About TMSVisit our website to find out how TMS can help your clinic provide vital support to those in need. #SuicidePreventionMonth #TMS #InterventionalPsychiatry #MentalHealthAwareness #DepressionTreatment #BlossomTMS #SaveLives
Unlocking Profitability in TMS: Why Blossom TMS is a Smart Investment
Transcranial Magnetic Stimulation (TMS) has rapidly become one of the most effective treatments for depression and other mental health conditions. As its popularity grows, many clinic owners are asking themselves: how profitable is TMS, and what’s the best device to maximize that profit? The Growing Demand for TMS TMS is in high demand due to its efficacy in treating Major Depressive Disorder (MDD) without the side effects often associated with medications. Many clinics have turned to TMS as a reliable revenue stream, with a significant return on investment (ROI). Clinics performing TMS can charge between $225 and $300 per session, with treatment courses typically ranging from 30 to 36 sessions. This offers clinics a strong potential for profitability. However, maximizing profitability depends not only on demand but also on controlling costs—especially in terms of the device you choose. The Hidden Costs of Pay-Per-Use Models Some TMS devices on the market come with a pay-per-use model, meaning clinics must pay a fee for every treatment they provide. While this model might seem manageable at first, these fees can accumulate over time, significantly reducing profits. Let’s break it down: • Even a conservative estimate of 3 patients a month on average, that is over 600 sessions in a year. At a pay-per-use rate of $65 per session, this can amount to an additional$39,000 annually—on top of the device’s initial cost. • Pay-per-use models often require special caps or coils that need frequent replacement, increasing operational costs and further reducing profitability. Blossom TMS: Designed for Long-Term Savings The Blossom TMS device offers a clear advantage by eliminating the pay-per-use model entirely. With no costly disposables or session fees, clinic owners can retain more of their revenue. Here’s how Blossom TMS helps clinics save: * No Pay-Per-Use Fees: Unlike other models, Blossom TMS doesn’t charge clinics for each session, providing a predictable cost structure.* No Expensive Disposables: Blossom TMS is built for long-term use, with industry-leading coil cooling technology that reduces the need for frequent replacements.* Energy Efficiency: Blossom TMS runs on a standard 120V US outlet, reducing energy consumption and operational costs. Maximizing ROI with TMS With the right TMS device, clinic owners can achieve a strong ROI. Clinics offering TMS treatments can generate large earnings annually, depending on session pricing and patient volume. Without the burden of pay-per-use fees, these earnings translate more directly into profit. When comparing TMS devices, it’s important to consider not only the upfront cost but also long-term expenses tied to disposables, pay-per-use fees, and energy consumption. Blossom TMS stands out for its cost-effective design that supports clinics in providing quality care without hidden overhead costs. The Takeaway For clinics looking to expand into TMS, profitability is well within reach—especially when avoiding costly pay-per-use models. By choosing Blossom TMS, you’re investing in a future of predictable costs, enhanced treatment options, and long-term profitability.
TMS: First-Line Treatment for Depression?
The landscape of mental health treatment is rapidly evolving, and Transcranial Magnetic Stimulation (TMS) is at the forefront of this transformation. Traditionally used as a secondary or last-resort treatment for individuals who did not respond to antidepressant medications, TMS is now being considered a first-line treatment option for depression by many psychiatrists and clinics. The shift towards TMS is driven by its growing body of clinical evidence, superior safety profile, and potential for long-term relief. The Case for TMS as a First-Line Treatment For decades, antidepressant medications have been the primary treatment for major depressive disorder (MDD). However, not all patients respond positively to these medications, and many experience adverse side effects such as weight gain, fatigue, and sexual dysfunction. Moreover, medications often need to be taken over a long period, and in some cases, patients must try multiple drugs before finding one that works, if they find relief at all. TMS offers an alternative. It is a non-invasive, drug-free treatment that uses magnetic pulses to stimulate areas of the brain involved in mood regulation. Multiple studies have demonstrated that TMS can achieve higher remission rates in patients with depression, with significantly fewer side effects compared to antidepressants. A large-scale clinical trial showed that TMS was more effective than additional antidepressants for treatment-resistant patients, and the success of TMS in this challenging population is contributing to its growing acceptance as a primary treatment option. Long-Term Relief with Minimal Side Effects A key reason behind the increased adoption of TMS is the long-term relief it offers. A typical TMS treatment protocol involves daily sessions over several weeks, and patients who respond positively often maintain their improvements for months or even years. Studies have shown that 68% of patients who benefit from TMS continue to experience positive outcomes for at least 12 months, reducing the need for ongoing treatments or medications. Moreover, TMS has a low side-effect profile. The most common side effects include mild scalp discomfort or headaches, which generally subside after the first few sessions. This contrasts with the more severe and persistent side effects often associated with antidepressant medications, making TMS an appealing option for those who prioritize quality of life and minimizing treatment-related discomfort. The Future of TMS As TMS continues to gain recognition, its potential to revolutionize depression treatment is becoming clearer. Advancements in TMS technology, including the development of more precise stimulation techniques and individualized treatment protocols, are improving its efficacy and accessibility. Additionally, insurance companies are expanding coverage for TMS, which is further removing barriers for patients seeking this cutting-edge therapy. With more clinics offering TMS and its success rate continuing to rise, it’s no surprise that psychiatrists are considering it as a first-line treatment for depression. The non-invasive nature, minimal side effects, and long-lasting relief make TMS a valuable tool in the fight against depression, offering hope for individuals who may have previously found their options limited. TMS is reshaping the future of depression treatment. As a first-line treatment, it holds significant promise for individuals suffering from MDD who are seeking effective, non-drug alternatives to traditional therapies. With more research supporting its efficacy and accessibility on the rise, TMS is poised to become a mainstay in the treatment of depression. Sources:
The History and Impact of the 10 Hz TMS Protocol: A Decade of Healing
Since the FDA approved the 10 Hz transcranial magnetic stimulation (TMS) protocol in 2008, this groundbreaking treatment has offered relief to tens of thousands of patients suffering from treatment-resistant depression worldwide. The 10 Hz protocol, targeting the left dorsolateral prefrontal cortex (DLPFC), has become a cornerstone of non-invasive brain stimulation therapies. Despite the advent of newer technologies like theta burst stimulation (iTBS), the 10 Hz protocol remains a highly effective and widely-used treatment in the field of psychiatry. The Origins of the 10 Hz Protocol The foundation for the 10 Hz TMS protocol was laid with several pioneering studies, but the gold standard study is the one conducted by O’Reardon et al. in 2007, which demonstrated that daily sessions of 10 Hz TMS were significantly more effective than sham treatments in reducing depression symptoms. This landmark study led directly to the FDA approval of TMS in 2008 as a treatment for major depressive disorder (MDD) in patients who had not responded to conventional treatments. How the Protocol Works The 10 Hz protocol involves delivering high-frequency pulses to the left DLPFC, an area of the brain associated with mood regulation. Each session traditionally lasted 37.5 minutes, delivering 3,000 pulses, but advancements in TMS technology have shortened session times to roughly 19 minutes over the years, improving patient comfort while maintaining the protocol’s efficacy. Proven Efficacy Over the Years The 10 Hz protocol’s ability to offer consistent and meaningful relief for individuals with depression has been proven in countless studies and patient experiences. Even after 16 years of clinical use, it continues to demonstrate high rates of remission and symptom reduction, helping patients who have not responded to antidepressants and psychotherapy. As noted in studies such as George et al. (2010), the protocol is especially beneficial for those with less treatment-resistant forms of depression, with remission rates significantly higher than sham treatments. The Rise of New Technologies: Theta Burst and Beyond In recent years, new neurostimulation technologies like intermittent theta burst stimulation (iTBS) have emerged, offering even shorter treatment times (as little as 3 minutes per session) without sacrificing efficacy. For example, the Blumberger et al. (2018) study highlighted the effectiveness of iTBS as a non-inferior alternative to 10 Hz, making it an attractive option for some clinics and patients( Additionally, recent advancements, such as those discussed in this 2021 study, continue to explore different TMS approaches. Yet, despite these innovations, the 10 Hz protocol remains a trusted and reliable option for clinics around the world. The Blossom TMS Device: Combining Tradition with Innovation For clinics looking to incorporate TMS therapy efficiently, the Blossom TMS device is an ideal solution. With its advanced cooling technology, it prevents overheating during sessions, allowing for shorter treatment times without sacrificing performance. The Blossom TMS device is designed to make the 10 Hz protocol more accessible by reducing the logistical barriers clinics often face, such as long session times or machine downtime. For any clinic ready to get TMS up and running quickly, the Blossom TMS device offers the perfect combination of efficiency and proven effectiveness. A Decade of Healing Since its introduction, the 10 Hz protocol has been pivotal in helping tens of thousands of patients around the globe. While the field of brain stimulation continues to evolve, the 10 Hz protocol remains a gold standard. It has stood the test of time, offering patients a reliable and effective treatment for over a decade. Even with the rise of faster protocols like iTBS, the 10 Hz protocol’s consistent ability to alleviate the debilitating symptoms of depression has ensured its place in the arsenal of treatments for MDD. As we look to the future, the 10 Hz protocol remains a symbol of hope and progress in the treatment of depression. It is a reminder that while new technologies will always emerge, sometimes the original solutions continue to provide the relief that patients need. The protocol’s success over the years speaks for itself, and it will undoubtedly continue to be a cornerstone of depression treatment worldwide.
TMS: It’s Covered!
Exploring the Journey of Insurance Coverage for Transcranial Magnetic Stimulation in the USA Transcranial Magnetic Stimulation (TMS) has emerged as a revolutionary treatment for various mental health conditions, offering hope to those who have not responded to traditional therapies. While the effectiveness of TMS has been well-documented, its accessibility has significantly hinged on insurance coverage. In this blog post, we delve into the history and evolution of insurance coverage for TMS in the United States, highlighting the milestones that have made this treatment more accessible to patients nationwide. Understanding TMS: A Brief Overview Before exploring the insurance landscape, it’s essential to understand what TMS entails. TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain, primarily used to treat depression and other mental health disorders. Approved by the FDA, TMS has proven effective for patients who have not found relief through medication or psychotherapy. The Early Days: Limited Recognition and Coverage 2008: FDA Approval Marks a Turning Point The journey of insurance coverage for TMS began in earnest in 2008, when the U.S. Food and Drug Administration (FDA) granted approval for its use in treating major depressive disorder (MDD) in adults who had not responded to antidepressant medications. This approval was a significant milestone, providing clinical validation for TMS and setting the stage for discussions around insurance coverage. 2009-2012: Initial Hesitancy and Gradual Acceptance Following FDA approval, insurance companies exhibited caution in adopting coverage for TMS therapy. The high cost of treatment and limited long-term data contributed to initial hesitancy. However, as more studies demonstrated the efficacy and safety of TMS, some regional and smaller insurance providers began to offer coverage on a case-by-case basis. Expansion and Standardization: Broadening Access 2012-2015: Major Insurers Come Onboard Between 2012 and 2015, several major insurance companies recognized the benefits of TMS and started providing coverage for eligible patients. Notable milestones during this period include: These decisions were influenced by accumulating clinical evidence, positive patient outcomes, and advocacy from mental health professionals emphasizing the need for diverse treatment options. 2016: Medicare Coverage Elevates Accessibility A significant breakthrough occurred in 2016 when Medicare started covering TMS therapy for depression. This development was pivotal for several reasons: Recent Developments: Wider Acceptance and Diverse Applications 2017-2020: Coverage for Additional Conditions As research expanded, demonstrating the efficacy of TMS for conditions beyond depression, insurance coverage began to reflect these findings: 2021-Present: Embracing Innovation and Accessibility In recent years, the landscape has continued to evolve positively: The Impact: Empowering Patients and Providers The progressive expansion of insurance coverage for TMS has had profound impacts: Looking Ahead: Continuing the Momentum While significant strides have been made, ongoing efforts are essential to further enhance coverage and access: The journey of insurance coverage for TMS in the United States reflects a dynamic interplay between clinical innovation, advocacy, and policy development. From initial skepticism to widespread acceptance, TMS has secured its place as a valuable tool in the mental health treatment arsenal, thanks in large part to evolving insurance policies that recognize its efficacy and importance. At SEBERS Medical, we are committed to staying at the forefront of these developments, ensuring that our patients have access to the most effective and innovative treatments available. TMS is not just a covered service; it’s a covered promise for better mental health and improved quality of life. For more information on TMS therapy and insurance coverage, feel free to contact us or visit our services page. Together, we can navigate the path to optimal mental health care.
The Quiet Power of Innovation: 3 Key Features of the Blossom TMS Device
When it comes to Transcranial Magnetic Stimulation (TMS), the technology behind the treatment is as critical as the therapy itself. At SEBERS Medical, we’ve taken every aspect of TMS therapy into consideration when designing the Blossom TMS device, ensuring it not only meets but exceeds the expectations of clinicians and patients alike. Here are three standout features that set the Blossom TMS device apart from the competition. 1. Plug-and-Play Simplicity: Powered by Standard 120-Volt Outlets One of the most significant advantages of the Blossom TMS device is its compatibility with standard 120-volt outlets. This feature simplifies installation and setup, making it incredibly easy for clinics to incorporate TMS therapy without needing expensive electrical modifications. Whether you’re in a large medical facility or a smaller outpatient clinic, the Blossom TMS device can be powered up and ready to go with the simple plug-and-play convenience. 2. Shhhh: Significantly Quieter Operation Several TMS devices rely on air cooling, which necessitates a hollow coil to allow airflow. While they can be effective, this design has a significant downside: it can be noisy. The Blossom TMS device, however, utilizes an innovative oil-cooling system that effectively suppresses this noise. The oil within the coil acts as a sound barrier, resulting in a much quieter operation. This quieter performance not only enhances patient comfort but also creates a more serene environment for both patients and clinicians. 3. Cool and Consistent: Maintaining Optimal Temperature with Oil Cooling Running cool is essential for any TMS device. The Blossom TMS device’s oil-cooling system isn’t just about reducing noise; it also ensures the coil remains at an optimal temperature throughout treatment. Our oil-cooled design maintains a consistent, cool temperature, promoting better performance and longevity. This feature not only safeguards the device’s internal components but also enhances the overall safety and effectiveness of each treatment session. The Blossom TMS device is a testament to the power of thoughtful design and engineering. With its ability to plug into standard outlets, operate quietly, and maintain a cool temperature during use, it’s clear that our focus is on delivering a superior experience for both clinicians and patients. These three key features highlight the innovation behind the Blossom TMS device, making it an ideal choice for any TMS provider looking to offer the best in patient care and clinical outcomes. About SEBERS Medical SEBERS Medical is a leading manufacturer of innovative medical devices, specializing in the production of the Blossom TMS device. Our mission is to advance mental health treatment through cutting-edge technology and exceptional quality. With a dedicated team of experts and a commitment to excellence, we strive to make a positive impact on the lives of those we serve. Contact Us: If you have any questions or would like more information about our products, please don’t hesitate to contact us. We are here to help! Stay connected with us for more updates and news by following our blog at https://sebersmedical.com/news/
Announcing the Digital Version of Blossom TMS Magazine!
We are thrilled to announce that the digital version of our acclaimed Blossom Burst TMS magazine is now available online! You can access the latest issue directly at https://blossomtms.com/tms-blossom-burst-magazine/ This digital edition is packed with insightful articles, expert opinions, and the latest advancements in TMS technology and mental health care. What You Can Expect In-Depth Articles: Our magazine features comprehensive articles on the latest trends and developments in Transcranial Magnetic Stimulation (TMS) therapy. From scientific breakthroughs to patient stories, we cover it all. Expert Insights: Read exclusive interviews and commentaries from leading professionals in the field of TMS and mental health. Gain valuable perspectives that can enhance your understanding and practice. Innovative Techniques: Learn about cutting-edge techniques and new applications of TMS therapy. Stay ahead of the curve with the most recent research and clinical practices. Highlights from the Latest Issue rTMS Therapy for Depression: This article delves into the effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) for treating depression. It provides an in-depth look at clinical trials, patient experiences, and expert opinions on this promising treatment method. Innovative Applications of TMS: Explore the latest research on how TMS is being used to treat a variety of mental health conditions beyond depression. This article highlights new studies and potential future applications of TMS technology. Expert Interview with Dr. Jane Smith: In this exclusive interview, Dr. Smith shares her insights on the evolution of TMS therapy and its impact on mental health treatment. Her perspectives offer valuable knowledge for both practitioners and patients. Instant Access Click here and get the latest issue delivered right to your inbox!! About SEBERS Medical SEBERS Medical is a leading manufacturer of innovative medical devices, specializing in the production of the Blossom TMS device. Our mission is to advance mental health treatment through cutting-edge technology and exceptional quality. With a dedicated team of experts and a commitment to excellence, we strive to make a positive impact on the lives of those we serve. Contact Us: If you have any questions or would like more information about our products, please don’t hesitate to contact us. We are here to help! Stay connected with us for more updates and news by following our blog at https://sebersmedical.com/news/
Blossom TMS Spotlight: Interview with Dr. Alex Lazar – Bliss TMS
Welcome to the Blossom Provider Spotlight series, where we highlight outstanding providers in the mental health field. This week, we’re thrilled to feature Dr. Alex Lazar, a highly experienced psychiatrist based in Encino, California. With over two decades of practice in adult and child psychiatry, Dr. Lazar has recently expanded his treatment offerings to include Transcranial Magnetic Stimulation (TMS), providing his patients with cutting-edge care for treatment-resistant depression and other mental health conditions. Interview with Dr. Alex Lazar – Bliss TMS Blossom TMS: What inspired you to pursue a career in psychiatry and mental health? Dr. Alex Lazar: My interest in psychiatry and mental health began during my medical school rotations. Psychiatry quickly became one of my favorite fields because I enjoyed talking to people about their stories and lives. It was fascinating to me, and that fascination led me to specialize in this area. Blossom TMS: How long have you been in practice, and where is your current practice located? Dr. Alex Lazar: I completed medical school in 1996 and went on to train in adult psychiatry at UCLA San Fernando, followed by child psychiatry at Cedars-Sinai Medical Center. I’ve been in private practice since 2001, so for about 23 years now. My practice is located in Encino, California, a suburb of Los Angeles. Blossom TMS: What first sparked your interest in TMS therapy, and how has your experience been so far? Dr. Alex Lazar: I had been practicing medication management and therapy for years, but I was always interested in exploring new treatment modalities. Although TMS has been around for a while, I initially had concerns about the barriers to entry, such as the cost of the machine and the learning curve. However, once I researched more and found a suitable machine and space in my office, I decided to move forward with it. My experience so far has been positive, and it’s rewarding to have another effective treatment option to offer my patients. Blossom TMS: Can you share any specific patient stories that highlight the impact of TMS therapy? Dr. Alex Lazar: I’ve had many patients who have seen significant improvements with TMS, especially those who were struggling with severe depression and had not responded to other treatments. One case that stands out is a young college student who began feeling much better after just 7 to 10 sessions. Another was a woman who had lost a child and was deeply depressed; she also experienced substantial improvement. While not every patient responds, the majority do, and the results can be quite profound. Blossom TMS: What do you find unique about the patient experience with TMS compared to other treatment modalities? Dr. Alex Lazar: One of the unique aspects of TMS is the frequency of visits, which allows for a closer connection with patients. Having them come into the office regularly helps build a stronger therapeutic relationship. However, the real effectiveness lies in the TMS treatment itself. It’s not just the increased interaction; TMS genuinely works for many patients. Blossom TMS: How has the scheduling of TMS sessions worked out for your patients? Dr. Alex Lazar: While TMS typically requires patients to come in five days a week, I’ve found that flexibility is key. Some patients can only manage three days a week due to their schedules, but they still see improvements. The important factor seems to be the total number of sessions rather than strictly adhering to a five-day-a-week schedule. Blossom TMS: What are your thoughts on the future of TMS therapy? Dr. Alex Lazar: I’m excited to see TMS being applied to more conditions beyond treatment-resistant depression and OCD. There’s ongoing research into its use for conditions like smoking cessation, tinnitus, migraines, and anxiety. I’m particularly interested in seeing how it might be used to treat bipolar depression, as I’ve had some promising results with that in my practice. Blossom TMS: What drew you to the Blossom TMS device, and how has it performed in your practice? Dr. Alex Lazar: The Blossom TMS device was a great fit for my practice because of its compact design, which is ideal for my smaller treatment room. The team at Blossom has been incredibly supportive and responsive, which made the transition smooth. The machine is user-friendly, and any issues I’ve encountered were quickly resolved. I’ve been very happy with my decision to go with Blossom. Blossom TMS: Is there anything else you’d like to share about your experience with TMS and Blossom? Dr. Alex Lazar: I’d just like to emphasize how pleased I am with both the results I’m seeing in my patients and the support I’ve received from Blossom TMS. The device is affordable and reliable, which makes it accessible for more providers and patients. I believe TMS has a bright future, and I’m glad to be part of that journey. To learn more about Blossom TMS, visit Seber’s Medical.
